SELUX DIAGNOSTICS
SeLux Diagnostics is a developer of the Next-Generation Phenotyping (NGP) platform that enables personalized antibiotic therapies for patients. The company was founded in 2014 and is based in Charlestown, MA.
SELUX DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2014-01-01
Address:
Charlestown, Massachusetts, United States
Country:
United States
Website Url:
http://www.seluxdx.com
Total Employee:
11+
Status:
Active
Contact:
617-945-9383
Email Addresses:
[email protected]
Total Funding:
172.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Exai Bio
Exai Bio is a next-generation Orphan non-coding RNAs and AI based liquid biospy company.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Juno Diagnostics
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
Current Advisors List
Current Employees Featured
Founder
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - SeLux Diagnostics
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - SeLux Diagnostics
RA Capital Management
RA Capital Management investment in Series C - SeLux Diagnostics
Schooner Capital
Schooner Capital investment in Series C - SeLux Diagnostics
Sands Capital Ventures
Sands Capital Ventures investment in Series C - SeLux Diagnostics
Northpond Ventures
Northpond Ventures investment in Series C - SeLux Diagnostics
National Institutes of Health
National Institutes of Health investment in Grant - SeLux Diagnostics
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - SeLux Diagnostics
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - SeLux Diagnostics
Northpond Ventures
Northpond Ventures investment in Series B - SeLux Diagnostics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-16 | Selux Diagnostics Announces Appointment of John Wilson as Chief Commercial Officer |
Official Site Inspections
http://www.seluxdx.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K
- Host name: 54.0.153.160.host.secureserver.net
- IP address: 160.153.0.54
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
